Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database.

Saved in:
Bibliographic Details
Title: Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database.
Authors: Martin-Pinardel R; Fundacio Clinic per la Recerca Biomedica, Barcelona, Spain.; IDIBAPS, Barcelona, Catalunya, Spain.; School of Medicine, University of Barcelona, Barcelona, Spain., Izquierdo-Serra J; School of Medicine, University of Barcelona, Barcelona, Spain.; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Bernal-Morales C; IDIBAPS, Barcelona, Catalunya, Spain.; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., De Zanet S; RetinAI US Inc, Boston, MA, USA.; Ikerian AG, Bern, Switzerland., Garay-Aramburu G; Ophthalmology, OSI Bilbao-Basurto, Bilbao, País Vasco, Spain., Puzo M; Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Aragón, Spain., Arruabarrena C; Retina section, Hospital Príncipe de Asturias, Alcalá de Henares, Spain.; Novovision, Madrid, Spain., Sararols L; Ophthalmology, Fundació Privada Hospital Asil Granollers, Granollers, Catalunya, Spain., Abraldes M; Ophthalmology, Hospital Universitario de Conxo, Santiago de Compostela, Spain., Broc L; Hospital Universitari Germans Trias i Pujol, Badalona, Catalunya, Spain., Escobar-Barranco JJ; Hospital Dos de Maig, Barcelona, Catalunya, Spain., Figueroa M; Department of Ophthalmology, Hospital Universitario Ramón y Cajal, Madrid, Spain., Zapata MA; Ophthalmology, Hospital Vall d'Hebron, Barcelona, Spain., Ruiz-Moreno JM; Ophthalmology, Castilla-La Mancha University, Albacete, Spain., Parrado-Carrillo A; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Moll-Udina A; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Alforja S; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Figueras-Roca M; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain., Gómez-Baldó L; Medical Department, Novartis Farmacéutica SA, Barcelona, Spain., Ciller C; RetinAI US Inc, Boston, MA, USA.; Ikerian AG, Bern, Switzerland., Apostolopoulos S; RetinAI US Inc, Boston, MA, USA.; Ikerian AG, Bern, Switzerland., Mishchuk A; RetinAI US Inc, Boston, MA, USA.; Ikerian AG, Bern, Switzerland., Casaroli-Marano RP; School of Medicine, University of Barcelona, Barcelona, Spain.; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.; Department of Surgery, University of Barcelona, Barcelona, Spain., Zarranz-Ventura J; Fundacio Clinic per la Recerca Biomedica, Barcelona, Spain jzarranz@hotmail.com.; IDIBAPS, Barcelona, Catalunya, Spain.; School of Medicine, University of Barcelona, Barcelona, Spain.; Hospital Clinic de Barcelona, Barcelona, Catalunya, Spain.
Corporate Authors: from the FRB SPAIN-IMAGE Project Investigators
Source: The British journal of ophthalmology [Br J Ophthalmol] 2025 Sep 23; Vol. 109 (10), pp. 1161-1170. Date of Electronic Publication: 2025 Sep 23.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Electronic Cited Medium: Internet ISSN: 1468-2079 (Electronic) Linking ISSN: 00071161 NLM ISO Abbreviation: Br J Ophthalmol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2079
DOI:10.1136/bjo-2024-325615